Patents for A61P 5 - Drugs for disorders of the endocrine system (28,908) |
---|
12/21/2006 | US20060287227 Gonadal function improving agents |
12/21/2006 | US20060287223 Remodeling and glycoconjugation of peptides |
12/21/2006 | US20060286150 Prevent menopause syndrome; therapy for skin aging; topical applying |
12/21/2006 | US20060286125 Immunomodulation; Yatapoxvirus polypeptide; multiple sclerosis, psoriasis, atopic dermatitis, type 1 insulin-dependent diabetes mellitus, dermatitis, Sjoigren's syndrome, encephalitis, Reiter's syndrome, psoriatic arthritis, progressive systemic sclerosis, primary biliary cirrhosis |
12/21/2006 | US20060286107 Parathyroid hormone antibodies and related methods |
12/21/2006 | CA2610222A1 Steroids having a mixed androgenic and progestagenic profile |
12/20/2006 | EP1733734A2 Placental alkaline phosphatase to control diabetes |
12/20/2006 | EP1733732A1 Insulin resistance improving agent |
12/20/2006 | EP1733727A1 Ferrocenecarboxamide derivatives for use as dopamine D3 ligands for the treatment of CNS disorders |
12/20/2006 | EP1732921A1 Thioamide derivatives as progesterone receptor modulators |
12/20/2006 | EP1732890A1 Crystalline polymorph of a bazedoxifene acetate |
12/20/2006 | EP1732889A1 Crystalline polymorph of bazedoxifene acetate |
12/20/2006 | EP1732888A1 Bazedoxifene ascorbate as selective estrogen receptor modulator |
12/20/2006 | EP1506200B1 Diazabicyclic biaryl derivatives |
12/20/2006 | EP1438310B1 Beta-carbolin derivatives as ptp-inhibitors |
12/20/2006 | EP1372665B1 Hormone replacement therapy method and its administration form |
12/20/2006 | EP0858336B1 Method and pharmaceutical composition for regulating lipid concentration |
12/20/2006 | CN1879630A Pharmaceutical compositions and uses for androst-5-ene-3 beta,17 beta-diol |
12/20/2006 | CN1879629A Estrogen replacement therapy |
12/20/2006 | CN1290848C Beta-amino tetrahydroimidazo (1,2-a) pyrazines and ahydrotrioazolo (4,3-a) pyrazines as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
12/20/2006 | CN1290813C Process for the preparation of non-steroidal glucocorticoid receptor modulators |
12/20/2006 | CN1290518C Extracting method of propolis effective component and its use |
12/20/2006 | CN1290507C Steroid hormone products and preparing method thereof |
12/19/2006 | US7151191 Such as 3-(4-salicyloylamino)phenoxypropionic acid; noncovalent drug delivery |
12/19/2006 | US7151109 Psychological disorders; anxiolytic agents; antidepressants |
12/14/2006 | WO2006132442A1 Vitamin d-like compound |
12/14/2006 | WO2006132295A1 Regulator of aldosterone receptor |
12/14/2006 | WO2006131799A2 Compositions based on phyto-oestrogen extracts for the treatment of menopausal and pre-menstrual syndrome, benign prostate hypertrophy, and polycystic ovary syndrome |
12/14/2006 | WO2006111776A3 Pharmaceutical composition comprising serum obtained from a naive mammal |
12/14/2006 | US20060281761 Osteoporosis; oral diseases; bone disorders; atherosclerosis; antiarthritic agents; autoimmune disease; cachexia |
12/14/2006 | US20060281719 Oestrogen-17-sulphamates as inhibitors of steroid sulphatase |
12/14/2006 | US20060281685 biodrug as antitumor agents; hormone sensitive tumors; therapy for prostate gland or breast cancer |
12/14/2006 | US20060281679 Human FGF-23 gene and gene expression products |
12/14/2006 | US20060280719 An addition polymer from an unsaturated monomer containing a phosphonate group and a phosphinate group separated from eachother by an optionally fluorinated methylene group; treatment of hyperphosphotemia, chronic renal failure, hyperparathyroidism, uremic bone disease, or osteoporosis |
12/13/2006 | EP1731168A1 Antibody drug |
12/13/2006 | EP1731157A2 Pharmaceutical compositions and uses for androst-5-ene-3 beta,17 beta-diol |
12/13/2006 | EP1730268A2 Differentiation of stem cells to endoderm and pancreatic lineage |
12/13/2006 | EP1730155A1 Thienopyrroles as antagonists of gnrh |
12/13/2006 | EP1730127A1 Heterocyclic phenylaminopropanol derivatives as modulators of the monoamine reuptake for the treatment of vasomotor symptoms (vms) |
12/13/2006 | EP1729776A1 Pyrrole derivatives as gonadotropin releasing hormone (gnrh) antagonists |
12/13/2006 | EP1729756A2 Novel pharmaceutical compositions |
12/13/2006 | EP1328252B1 Transdermal pharmaceutical delivery composition |
12/13/2006 | EP1143989B1 Exendins for glucagon suppression |
12/13/2006 | CN1878548A Combinations of at1-antagonists, amiloride or triamterine, and a diuretic. |
12/13/2006 | CN1876677A Novel lhrh antagonists, preparation method and pharmaceutical use thereof |
12/13/2006 | CN1875994A Strain of lactic acid bacterium and edible compositions, drugs and veterinary products containing it |
12/13/2006 | CN1875977A Use of tanshinone compound in preparation of medicine for treating Grave's disease |
12/13/2006 | CN1289143C Method for reducing decreasing blood-glucose and delaying weight increase of diabetic |
12/13/2006 | CN1289082C Medicine composition for treating diabetes |
12/13/2006 | CN1289073C Hair growth stimulant |
12/13/2006 | CN1289064C Drug delivery system |
12/12/2006 | US7148247 Substituted benzoxazoles as estrogenic agents |
12/12/2006 | US7148213 Steroids with fluoroalkyl groups as antigestation steroids used in gynecological treatment |
12/12/2006 | US7148195 Antitumor agents; hormone sensitive tumors; therapy for prostate gland or breast cancer |
12/12/2006 | CA2154161C Therapeutic uses and delivery systems of dehydroepiandrosterone |
12/07/2006 | WO2006129995A1 Stabilized parathyroid hormone composition comprising parathyroid hormone, buffer and stabilizing agent |
12/07/2006 | WO2006129826A1 Novel piperidine derivative |
12/07/2006 | WO2006129784A1 INTERFERON-α REGULATOR |
12/07/2006 | WO2006129076A1 Use of a steroid sulphatase inhibitor for inhibiting the synthesis of androstenedione and/or testosterone |
12/07/2006 | WO2006128852A2 Heterocyclic spiro-compounds as aldosterone synthase inhibitors |
12/07/2006 | WO2006128851A1 Fused imidazole derivatives and use thereof as aldosterone synthase inhibitors |
12/07/2006 | WO2006128337A1 A pharmaceutical composition for prevention and treatment of menopausal syndrome and method of preparing the same |
12/07/2006 | US20060276456 Such as [1,1-biphenyl]-4-yl-(5,11-dihydro-10H-dibenzo[b,e][1,4]diazepin-10-yl)methanone; for treatment of diabetes insipidus, nocturnal enuresis, nocturia, urinary incontinence, or hemophilia |
12/07/2006 | US20060276443 21-substituted progesterone derivatives as new antiprogestational agents |
12/07/2006 | US20060275284 Combination therapy for treatment of autoimmune diseases using b-cell depleting/immunoregulatory antibody combination |
12/07/2006 | DE60118395T2 Pharmazeutische zusammensetzungen mit verzögerter freisetzung für die parenterale applikation von hydrophilen wirkstoffen Pharmaceutical compositions of active ingredients with controlled release for the parenteral administration of hydrophilic |
12/07/2006 | CA2609930A1 Fused imidazole derivatives and use thereof as aldosterone synthase inhibitors |
12/07/2006 | CA2609818A1 Use of a steroid sulphatase inhibitor for inhibiting the synthesis of androstenedione and/or testosterone |
12/07/2006 | CA2609660A1 Heterocyclic spiro-compounds as aldosterone synthase inhibitors |
12/07/2006 | CA2609388A1 Novel piperidine derivative |
12/06/2006 | EP1727555A1 Production of hop extracts having oestrogenic and antiproliferative bioactivity |
12/06/2006 | EP1456212B1 6-aminomorphinane derivatives, method for the production and use thereof |
12/06/2006 | EP1446128B1 Use of estrogenic compounds in combination with progestogenic compounds in hormone-replacement therapy |
12/06/2006 | EP1091738B1 BICYCLIC sPLA 2 INHIBITORS |
12/06/2006 | CN1874765A Accelerator for initial insulin secretion |
12/06/2006 | CN1872997A New technique for culturing stem cells (carrying therapy gene) of human's xenogenic stromata in large-scale |
12/06/2006 | CN1872344A Gene therapy method of stem cell (carrying therapy gene) of human xenogenic stroma |
12/06/2006 | CN1288148C 1,2,3,4-tetrahydroisoquinolines derivatives as urotensin II receptor antagonists |
12/05/2006 | USRE39419 Estrogen agonist/antagonist metabolites |
12/05/2006 | US7145015 Benzocycloheptenes, process for their production, pharmaceutical preparations that contain that latter as well as their use for the production of pharmaceutical agents |
12/05/2006 | US7144909 Phenoxy substituted benzocondensed heteroaryl derivatives as thyroid receptor ligands |
12/05/2006 | US7144900 Pharmaceutical composition |
12/05/2006 | US7144845 Compounds useful in the manufacture of an anti-inflammatory androstane derivative |
12/05/2006 | US7144707 Determination of risk and treatment of complications of prematurity |
12/05/2006 | US7144586 Compositions for preventing hormone induced adverse effects |
12/05/2006 | CA2531834C Pharmaceutical compositions comprising pioglitazone and an insulin secretion enhancer |
11/30/2006 | WO2006127941A2 Amorphous cinacalcet hydrochloride and preparation thereof |
11/30/2006 | WO2006127932A2 Purification of cinacalcet |
11/30/2006 | WO2006127057A1 Non-systematic vaginal administration of estrogen and an androgen for the treatment of sexual dysfunction |
11/30/2006 | WO2006126718A1 Pyrazolopyrimidine derivative |
11/30/2006 | WO2006126673A1 Combined drug for treating diabetes |
11/30/2006 | WO2006126514A1 Arylacetate derivative having isoxazole skeleton |
11/30/2006 | WO2006125800A1 17β-HSD1 AND STS INHIBITORS |
11/30/2006 | WO2006125642A1 Methods and apparatus for transdermal or transmucosal application of testosterone |
11/30/2006 | WO2006125285A1 Insulin sensitization to slow down pubertal tempo and to augment pubertal growth |
11/30/2006 | US20060270687 Such as n-(4-fluorobenzyl)-6-(4-methyl-1H-imidazol-1-yl)pyrazin-2-amine; protein kinase associated disease states |
11/30/2006 | US20060270681 Pyridazine derivatives |
11/30/2006 | US20060270679 Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
11/30/2006 | US20060270660 Processes for preparing substituted pyrimidines |
11/30/2006 | US20060270649 Azetidine derivatives, their preparation and medicaments containing them |